Main > ONCOLOGY (**) > NasoPharingeal Carcinoma (NPC) > TREAT.: > CN. J. Anti PD-1 MAb+CT

---

CN. J. Anti PD-1 MAb+CT's subsections
(*) CN Approval Date: 2021. 11.29
(*) USA Approval Date: 2023. 10.27
Company
Company Marketing USA
Generic Name
Locally Recurrent or Metastatic
Patent>CN Patent
Patent>USA Patent Numbers
PR Web-Site CN
PR Web-Site USA

CN. J. Anti PD-1 MAb+CT's products
This section has no products